Browse our collection of papers in
Pharmaceutical Industry
C/B/2265. Strategic directions of pharmaceutical companies GSK, Pfizer and Novartis
- WORDS:
- 1250
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper examines the strategic development of companies operating in the pharmaceutical industry, i.e. GlaxoSmithKline (GSK), Pfizer and Novartis. Key competences, capabilities and resources of GSK are discussed with references to the theory of strategy.
KEYWORDS: GlaxoSmithKline, GSK, Pfizer, Novartis, pharmaceutical industry, strategic directions,
C/B/2192. Company Strategies in Pharmaceutical Industry: Ansoff Analysis of Johnson & Johnson, Pfizer and Merck
- WORDS:
- 1500
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper examines strategic directions in the development of three pharmaceutical companies, Johnson & Johnson (J&J), Pfizer and Merck describing the current situation within the industry and conducting comparative analysis of the companies’ products and markets using Ansoff matrix.
KEYWORDS: Pharmaceutical Industry, Ansoff Matrix, Johnson & Johnson, J&J, Pfizer, Merck,
C/B/2157. Strategic Direction of Pharmaceutical and Biotechnological Companies
- WORDS:
- 2200
- DATE:
- 2010
- PRICE:
- 29.99 GBP
The paper looks at the ongoing changes in the pharmaceutical (pharma) and biotechnological (biotech) industries addressing the challenges facing pharma and biotech companies, i.e. the safety and quality of their products, the pricing of medicines, and the need to engage in profitable commercial relations. Competitive strategies of Johnson & Johnson (J&J), Merck and Pfizer are described, key competences and capabilities of J&J are identified.
KEYWORDS: Pharmaceutical, biotechnological, medicines, Johnson & Johnson, J&J, Merck and Pfizer,
C/B/2156. Using Johnson & Johnson, Pfizer and Merck, identify the strategic direction, which each has chosen, from their websites and other sources. Using appropriate models and theory compare and contrast their strategies and judge which are most likely to succeed in the future. Identify the key competences, capabilities and resources held by 'one' of the companies chosen for the first part of this assignment. How well equipped is it to meet future challenges?
- WORDS:
- 2200
- DATE:
- 2010
- PRICE:
- 29.99 GBP
The paper looks at the ongoing changes in the pharmaceutical (pharma) and biotechnological (biotech) industries addressing the challenges facing pharma and biotech companies, i.e. the safety and quality of their products, the pricing of medicines, and the need to engage in profitable commercial relations. Competitive strategies of Johnson & Johnson (J&J), Merck and Pfizer are described, key competences and capabilities of J&J are identified.
KEYWORDS: Pharmaceutical, biotechnological, medicines, Johnson & Johnson, J&J, Merck and Pfizer,
C/B/2111. Corporate social responsibility in pharmaceutical industry: case study of GlaxoSmithKline
- WORDS:
- 1000
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper describes the environment of the pharmaceutical industry highlighting its challenges and threats, addressing the issues of corporate social responsibility (CSR) faced by pharmaceutical companies, and examining the mission of GlaxoSmithKline (GSK) with regard to their CSR implementation.
KEYWORDS: pharmaceutical industry, GlaxoSmithKline, GSK, corporate social responsibility, CSR,
C/HR/569. Dissertation. HR practices in India and their contribution towards business success in Indian pharmaceutical industry
- WORDS:
- 19700
- DATE:
- 2009
- PRICE:
- 199.99 GBP
The dissertation investigates the influence of human resource management (HRM) practices on the individual performance and organisational outcome of the pharmaceutical companies in India. The Introduction provides the rationale for the research subject choice describing the situation within Indian pharmaceutical industry and related HRM issues. The review of literature touches on the theory of HRM including strategic HRM, HRM tools and practices, etc. The methods of the research are based on qualitative and quantitative analysis including statistic analysis of the primary data obtained via an online questionnaire. Conclusions are made about the perceptions, attitudes and experiences of managers and employees in Indian pharmaceutical companies regarding the impact of HRM practices on the organisational performance.
KEYWORDS: Dissertation, HRM, pharmaceutical industry, India, organisational performance,
C/M/1228. Change drivers in pharmaceutical industry: challenges and solutions
- WORDS:
- 1700
- DATE:
- 2009
- PRICE:
- 19.99 GBP
The paper examines the drivers of change within the pharmaceutical industry suggesting the use of ‘force field’ and SWOT analysis to identify the factors that need to be changed and the factors that resist change. Recommendations about change management in pharmaceutical companies are suggested arguing that they can no longer rely on the promotion of primary care products for mass market consumption, highlighting the need for extensive research and development (R&D), and discussing the Pugh’s change matrix.
KEYWORDS: Organisational Change, Pharmaceutical Industry, Change Drivers, research and development, R&D, Pugh’s change matrix,
C/F/560. Strategic Financial Analysis of AstraZeneca and GlaxoSmithKline
- WORDS:
- 3100
- DATE:
- 2009
- PRICE:
- 39.99 GBP
The paper examines the factors that affected the financial performance of AstraZeneca (AZN) and GlaxoSmithKline (GSK) giving particular focus to the analysis of the product portfolio and recent developments in the pharmaceutical industry. An overview of the companies’ ratios over 2004-2008 is provided suggesting recommendations for the investors.
KEYWORDS: GlaxoSmithKline, GSK, AstraZeneca, AZN, pharmaceutical industry,
C/M/902. Relationship Marketing and the Internet in Pharmaceutical Industry
- WORDS:
- 6500
- DATE:
- 2008
- PRICE:
- 69.99 GBP
The paper examines how the Internet and relationship marketing can contribute to the pharmaceutical industry, helping pharmaceutical companies to gain access to physicians and build customer loyalty. A review of related literature is presented discussing the move from traditional marketing and customer acquisition to relationship marketing and customer loyalty. The changes of customer loyalty in an online environment and their implications for the pharmaceutical industry are considered.
KEYWORDS: Internet, relationship marketing, customer loyalty, e-loyalty, pharmaceutical industry,
C/M/909. Relationship Marketing and the Internet in Pharmaceutical Industry
- WORDS:
- 4000
- DATE:
- 2008
- PRICE:
- 49.99 GBP
The paper examines how the Internet and relationship marketing can contribute to the pharmaceutical industry by helping pharmaceutical companies to gain access to physicians and build customer loyalty. Literature is reviewed focusing on the move from traditional marketing and customer acquisition to relationship marketing and customer loyalty. The implications of these changes for the pharmaceutical industry are considered.
KEYWORDS: Relationship marketing, customer loyalty, e-loyalty, pharmaceutical industry,
C/M/934. Marketing Analysis for OTC companies in Gastrointestinal category: importance of CRM with Pharmacies
- WORDS:
- 1700
- DATE:
- 2008
- PRICE:
- 19.99 GBP
The paper examines the relationship between the UK healthcare (HC) industry and the over-the-counter medicine (OCT) industry addressing the significance of customer relationship management (CRM) towards pharmacies. OTC markets are analyzed using Porter's Five Forces, PESTEL, STP (Segmentation, Targeting and Positioning), 7 Ps and 4 Ps models. Conclusions are made about the need to strengthen CRM ties between the supplier and pharmacy.
KEYWORDS: Customer Relationship Management, CRM, PESTEL, Porters Five Forces, 7 Ps, 4 Ps, STP,
C/B/707. PowerPoint Presentation. Collaborative Strategies in Pharmaceutical Industry
- WORDS:
- 0
- ADD-ONS:
- 12 Slides
- DATE:
- 2007
- PRICE:
- 19.99 GBP
The power point presentation discusses the collaborative strategies in Pharmaceutical Industry
KEYWORDS: Collaborative strategy, Pharmaceutical industry,
C/B/723. EU Enlargement and the UK Pharmaceutical Industry
- WORDS:
- 2000
- DATE:
- 2007
- PRICE:
- 29.99 GBP
In May 2004, 10 new countries joined the European Union (EU), thereby increasing the member states from 15 to 25. A number of key factors can be identified as having the greatest impact on the UK pharmaceutical industry during the post-accession of these states. This report has been aimed at analyzing these impacts of EU enlargement on the overall UK pharmaceutical industry.
KEYWORDS: European Union, pharmaceutical industry, UK,
C/B/731. High-potent drug market: Investment perspective
- WORDS:
- 2000
- DATE:
- 2007
- PRICE:
- 29.99 GBP
The project proposal would analyse the market of high-potency drug market in terms of the market dynamics, economics and competitive landscape. It would also try to examine the merit of investing in more up-to-date technology to produce high-potency drugs for the market.
KEYWORDS: High-potent drug industry, pharmaceutical industry, industry analysis,
C/B/836. External Environment Analysis: Pharmaceutical Manufacturers
- WORDS:
- 2400
- DATE:
- 2007
- PRICE:
- 29.99 GBP
The paper presents an overview of the external environment of the Pharmaceutical manufacturers within the UK using PESTEL and Porter's Five Forces analysis and providing conclusions based on the analysis.
KEYWORDS: Pharmaceutical manufacturers, PESTEL, Porters Five Forces,
S/OM/45. Innovation & Imitation in an Industrial Organization ? Pharmaceutical Industry
- WORDS:
- 8500
- DATE:
- 2007
- PRICE:
- 89.99 GBP
The paper examines the role of innovation and imitation of other firms in the development of an organization providing a review of academic literature on the types of innovation, the theory of uncertainty and decision making, knowledge diffusion, etc. Innovation in the pharmaceutical industry is analysed outlining the challenges of pharmaceutical manufacturing, the relationships between scientific research and industrial innovation, the issues of intellectual property, pharmaceutical market structure, incentives for innovation, etc.
KEYWORDS: Innovation, imitation, pharmaceutical,
C/B/363. Pharmaceutical Industry Structural Analysis
- WORDS:
- 2400
- DATE:
- 2006
- PRICE:
- 29.99 GBP
This essay links the underlying industry structure with its competitive environment and potential strategic routes available for a firm within the industry. In order to achieve the objective of this essay Pharmaceutical Industry has been used as a case study to understand the dynamics governing the structure of the industry. The essay has adopted one of the most widely used models in the business studies, Porters Five Forces as its key framework for the purpose of analysis.
KEYWORDS: pharmaceutical, industry, structural,
C/B/451. Pfizer: Structure and strategy in the pharmaceutical industry (global perspective)
- WORDS:
- 1950
- DATE:
- 2006
- PRICE:
- 19.99 GBP
This paper examines trends in the macro-environment through PESTEL while the industry structure is analysed with the help of Porter's Five Forces. The analysis of Pfizer, the world's biggest pharmaceutical company, will be presented through a SWOT that will help us understand what is at stake.
KEYWORDS: Pfizer, PESTEL, SWOT, Porters Five Forces, drugs, pharmaceutical industry,
E/B/210. Analysis of pharmaceutical industry
- WORDS:
- 2500
- DATE:
- 2006
- PRICE:
- 29.99 GBP
The paper examines the macro environment of the pharmaceutical industry conducting its STEP (PEST) analysis and identifying market trends within the industry. Analysis of the Indian pharmaceutical industry is conducted using the models of Porter's Five Forces and Generic Strategies.
KEYWORDS: Pharmaceutical industry, STEP, PEST, Porters Five Forces,
E/M/208. Pfizer's position in pharmaceutical industry
- WORDS:
- 1500
- DATE:
- 2006
- PRICE:
- 19.99 GBP
The paper reports on the pharmaceutical company Pfizer offering an overview of the industry environment and the development of pharmaceutical products. Analysis is conducted of Pfizer's micro-environment discussing their Marketing Mix features and suggesting recommendations about the company's business and financial strategies.
KEYWORDS: Pfizer, pharmaceutical, marketing mix,
P/B/644. Pharmaceutical crisis and new drugs development
- WORDS:
- 2000
- DATE:
- 2006
- PRICE:
- 29.99 GBP
The paper examines the causes of the difficulty in developing new drugs reviewing the current problems in the pharmaceutical industry related to the patent system, the emergence of new competitors, the ‘blockbuster’ model, the complexity of the research and development (R&D) process, the role of the government, etc.
KEYWORDS: Parmaceutical, drugs, patent,
P/B/712. Global pharmaceutical industry: problems and forecasts
- WORDS:
- 3000
- DATE:
- 2006
- PRICE:
- 39.99 GBP
The paper reports on the pharmaceutical industry discussing the implications of the global regulatory approval, the role of ?blockbuster? drugs, the rising costs of research and development projects, the generic drugs competition, etc. Forecasts are made suggesting various scenarios of the industry development.
KEYWORDS: Pharmaceutical, drugs, research and development, R&D, forecast,
P/B/840. GlaxoSmithKline (GSK) mergers and pharmaceutical industry
- WORDS:
- 4500
- DATE:
- 2006
- PRICE:
- 49.99 GBP
The paper reports on the pharmaceutical company GlaxoSmithKline (GSK) presenting an overview of the pharmaceutical industry, discussing the role of research and development (R&D) departments for pharmaceutical companies, etc. The history of GSK mergers is reviewed providing a critical analysis of the merger process and outlining future opportunities and threats.
KEYWORDS: glaxosmithkline, gsk, mergers, pharmaceutical, industry,
S/B/153. Drug problem under globalization
- WORDS:
- 2500
- DATE:
- 2006
- PRICE:
- 29.99 GBP
The paper addresses the problem of drug trafficking under globalization reviewing the situation in the world drug market, the US war on drugs, etc. Medical and social consequences of illicit drug use are outlined and discussed.
KEYWORDS: Drug, globalization, addiction, death, crime,
S/F/102. Dissertation. Mergers and Acquisitions in the Pharmaceuticals Industry: A Study of the Pre and Post Merger Performance between Glaxowellcome and Smithline Beecham
- WORDS:
- 10500
- DATE:
- 2006
- PRICE:
- 109.99 GBP
The dissertation investigates the performance of GlaxoSmithKline (GSK) form their pre-merger through to the post merger periods providing a review of literature on the theory of mergers and acquisitions (M&A), an overview of the pharmaceutical industry and GSK background including their financial and operational review, performance analysis, etc. The methods of research are based on primary (interviews) and secondary data sources. Conclusions are made about the pre and post merger financial, operational, and value creation performance of GSK.
KEYWORDS: Dissertation, GSK, GlaxoSmithKline, merger, M&A,
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
First of all thank you very much for the paper. You know while trying your services, to be honest, I was very scared, but finally all that fear has gone now. This proposal will really help me and I will definitely use your services again.Singh
